<codeBook xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xsi:schemaLocation="ddi:codebook:2_5 http://www.ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd" xmlns="ddi:codebook:2_5">
  <docDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</titl>
        <altTitl>Treatment with RαMH or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</altTitl>
        <parTitl xml:lang="en">Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</parTitl>
        <IDNo agency="SND">2024-467-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.5878/hg1a-sd78</IDNo>
      </titlStmt>
      <prodStmt>
        <producer xml:lang="en" abbr="SND">Swedish National Data Service</producer>
        <producer xml:lang="sv" abbr="SND">Svensk nationell datatjänst</producer>
      </prodStmt>
      <holdings URI="https://doi.org/10.5878/hg1a-sd78">Landing page</holdings>
    </citation>
  </docDscr>
  <stdyDscr>
    <citation>
      <titlStmt>
        <titl xml:lang="sv">Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</titl>
        <altTitl>Treatment with RαMH or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</altTitl>
        <parTitl xml:lang="en">Treatment with (R)-α-methylhistamine or IL4 stimulates mucin production and decreases Helicobacter pylori density in the murine stomach</parTitl>
        <IDNo agency="SND">2024-467-1</IDNo>
        <IDNo agency="DOI">https://doi.org/10.5878/hg1a-sd78</IDNo>
        <IDNo agency="DOI">10.1080/21505594.2019.1573050</IDNo>
        <IDNo agency="DOI">10.1128/IAI.01000-12</IDNo>
        <IDNo agency="DOI">10.1023/a:1018841204104</IDNo>
      </titlStmt>
      <rspStmt>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biochemistry and Cell biology, University of Gothenburg">Santos, Licínia</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Avdelningen för medicinsk kemi och cellbiologi, Göteborgs universitet">Santos, Licínia</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biochemistry and Cell biology, University of Gothenburg">Sharba, Sinan</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Avdelningen för medicinsk kemi och cellbiologi, Göteborgs universitet">Sharba, Sinan</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biochemistry and Cell biology, University of Gothenburg">Benktander, John</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Avdelningen för medicinsk kemi och cellbiologi, Göteborgs universitet">Benktander, John</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="University of Gothenburg">Ojaimi Loibman, Stefany</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Göteborgs universitet">Ojaimi Loibman, Stefany</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="University of Gothenburg">Quintana-Hayashi, Macarena P.</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Göteborgs universitet">Quintana-Hayashi, Macarena P.</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biochemistry and Cell biology, University of Gothenburg">Erhardsson, Mattias</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Avdelningen för medicinsk kemi och cellbiologi, Göteborgs universitet">Erhardsson, Mattias</AuthEnty>
        <AuthEnty xml:lang="en" affiliation="Department of Medical Biochemistry and Cell biology, University of Gothenburg">Lindén, Sara K.</AuthEnty>
        <AuthEnty xml:lang="sv" affiliation="Avdelningen för medicinsk kemi och cellbiologi, Göteborgs universitet">Lindén, Sara K.</AuthEnty>
      </rspStmt>
      <prodStmt />
      <distStmt>
        <distrbtr xml:lang="en" abbr="SND" URI="https://snd.se">Swedish National Data Service</distrbtr>
        <distrbtr xml:lang="sv" abbr="SND" URI="https://snd.se">Svensk nationell datatjänst</distrbtr>
        <distDate xml:lang="en" date="2025-06-30" />
      </distStmt>
      <verStmt>
        <version elementVersion="1" elementVersionDate="2025-06-30" />
      </verStmt>
      <holdings URI="https://doi.org/10.5878/hg1a-sd78">Landing page</holdings>
    </citation>
    <stdyInfo>
      <subject>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009077">Mucins</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009077">Muciner</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009093">Mucus</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D009093">Slem</keyword>
        <keyword xml:lang="en" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D013270">Stomach</keyword>
        <keyword xml:lang="sv" vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D013270">Magsäck</keyword>
        <topcClas xml:lang="en" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=Health">HEALTH</topcClas>
        <topcClas xml:lang="sv" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=Health">HÄLSA</topcClas>
        <topcClas xml:lang="en" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=Health.MedicationAndTreatment">Medication and treatment</topcClas>
        <topcClas xml:lang="sv" vocab="CESSDA Topic Classification" vocabURI="https://vocabularies.cessda.eu/vocabulary/TopicClassification?code=Health.MedicationAndTreatment">Medicinering och behandlingar</topcClas>
      </subject>
      <abstract xml:lang="en" contentType="abstract">The histology data show the sum scores for each group used to calculate the results in percentages normalized to non-infected vehicle-treated or H. pylori-infected vehicle-treated mice allowing for pooling results from different experiments into the same graph.
The antibody levels determined by ELISA are presented in absorbance 450nm. 
The cell growth/viability was measured as the reducing potential of viable cell data presented in luminescence. 
The expression of virulence factor assessed by RT-PCR is expressed in fold-change.</abstract>
      <abstract xml:lang="sv" contentType="abstract">Histologiska data visar summapoängen för varje grupp som användes för att beräkna resultaten i procentandelar normaliserade till icke-infekterade vehikelbehandlade eller H. pylori-infekterade vehikelbehandlade möss, vilket möjliggör sammanslagning av resultat från olika experiment i samma graf.
Antikroppsnivåerna bestämda med ELISA presenteras i absorbans 450 nm.
Celltillväxten/viabiliteten mättes som den reducerande potentialen för viabla celldata presenterade i luminescens.
Uttrycket av virulensfaktor bedömd med RT-PCR uttrycks i veck-förändring.</abstract>
      <sumDscr>
        <collDate xml:lang="en" date="2021-04-22" event="start">2021-04-22</collDate>
        <collDate xml:lang="en" date="2021-05-06" event="end">2021-05-06</collDate>
        <collDate xml:lang="en" date="2021-11-17" event="start">2021-11-17</collDate>
        <collDate xml:lang="en" date="2021-12-02" event="end">2021-12-02</collDate>
        <collDate xml:lang="en" date="2022-03-24" event="start">2022-03-24</collDate>
        <collDate xml:lang="en" date="2022-04-09" event="end">2022-04-09</collDate>
        <collDate xml:lang="en" date="2022-09-07" event="start">2022-09-07</collDate>
        <collDate xml:lang="en" date="2022-09-22" event="end">2022-09-22</collDate>
        <anlyUnit xml:lang="en" unit="Other">Other<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=en-2.1.3">Other</concept></anlyUnit>
        <anlyUnit xml:lang="sv" unit="Övrigt">Övrigt<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=sv-2.1.3">Övrigt</concept></anlyUnit>
        <anlyUnit xml:lang="en" unit="Cells">Cells<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=en-2.1.3">Cells</concept></anlyUnit>
        <anlyUnit xml:lang="sv" unit="Celler">Celler<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=sv-2.1.3">Celler</concept></anlyUnit>
        <anlyUnit xml:lang="en" unit="Organ">Organ<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=en-2.1.3">Organ</concept></anlyUnit>
        <anlyUnit xml:lang="sv" unit="Organ">Organ<concept vocab="DDI Analysis Unit" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/AnalysisUnit/2.1.3?languageVersion=sv-2.1.3">Organ</concept></anlyUnit>
        <universe xml:lang="en">Mice were divided into different groups: non-infected vehicle-treated control, H. pylori vehicle-treated, H. pylori-infected RaMH-treated and H. pylori-infected Il4-treated.</universe>
        <universe xml:lang="sv">Möss delades in i olika grupper: icke-infekterad vehikelbehandlad kontroll, H. pylori-vehikelbehandlad, H. pylori-infekterad RaMH-behandlad och H. pylori-infekterad Il4-behandlad.</universe>
        <dataKind xml:lang="en">Numeric</dataKind>
        <dataKind xml:lang="en">Text</dataKind>
      </sumDscr>
    </stdyInfo>
    <method>
      <dataColl>
        <timeMeth xml:lang="en">Other<concept vocab="DDI Time Method" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/TimeMethod/1.2.3?languageVersion=en-1.2.3">Other</concept></timeMeth>
        <timeMeth xml:lang="sv">Övrigt<concept vocab="DDI Time Method" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/TimeMethod/1.2.3?languageVersion=sv-1.2.3">Övrigt</concept></timeMeth>
        <sampProc xml:lang="en">A total of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO and diluted in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons.
Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.<concept vocab="DDI Sampling Procedure" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/SamplingProcedure/2.0.1?languageVersion=en-2.0.1">A total of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO and diluted in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons.
Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.</concept></sampProc>
        <sampProc xml:lang="sv">Totalt 300 µl per mus framställdes genom att lösa 2,6 mg GalNAz i 50 µl DMSO och späddes i PBS. GalNAz-injektionerna gavs intraperitonealt 14 dagar efter infektion, och möss avlivades 2 timmar efter injektionen genom cervikal dislokation under anestesi med isofluran. Helblodsprover från varje mus samlades in vid avlivning. Därefter skördades magarna och öppnades längs den större krökningen följt av en försiktig tvätt i steril PBS för att avlägsna chyme. En remsa av magsäckens mindre krökning innehållande förmage, corpus och antrum fixerades i buffrad formaldehyd 4% vattenlösning i 24 timmar. Den fixerade vävnaden var paraffininbäddad och histologiska objektglas preparerades med 4 µm tjocka vävnadsband.
Dessutom samlades två delar av korpusen (ungefär 4 x 4 mm) upp. En placerades i RNA-later och lagrades vid 4°C, den andra frystes omedelbart i torris. Båda proverna förvarades senare vid -80°C fram till användning.<concept vocab="DDI Sampling Procedure" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/SamplingProcedure/2.0.1?languageVersion=sv-2.0.1">Totalt 300 µl per mus framställdes genom att lösa 2,6 mg GalNAz i 50 µl DMSO och späddes i PBS. GalNAz-injektionerna gavs intraperitonealt 14 dagar efter infektion, och möss avlivades 2 timmar efter injektionen genom cervikal dislokation under anestesi med isofluran. Helblodsprover från varje mus samlades in vid avlivning. Därefter skördades magarna och öppnades längs den större krökningen följt av en försiktig tvätt i steril PBS för att avlägsna chyme. En remsa av magsäckens mindre krökning innehållande förmage, corpus och antrum fixerades i buffrad formaldehyd 4% vattenlösning i 24 timmar. Den fixerade vävnaden var paraffininbäddad och histologiska objektglas preparerades med 4 µm tjocka vävnadsband.
Dessutom samlades två delar av korpusen (ungefär 4 x 4 mm) upp. En placerades i RNA-later och lagrades vid 4°C, den andra frystes omedelbart i torris. Båda proverna förvarades senare vid -80°C fram till användning.</concept></sampProc>
        <sampProc xml:lang="en">Other<concept vocab="DDI Sampling Procedure" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/SamplingProcedure/2.0.1?languageVersion=en-2.0.1">Other</concept></sampProc>
        <sampProc xml:lang="sv">Övrigt<concept vocab="DDI Sampling Procedure" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/SamplingProcedure/2.0.1?languageVersion=sv-2.0.1">Övrigt</concept></sampProc>
        <collMode xml:lang="en">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.</concept></collMode>
        <collMode xml:lang="en">Measurements and tests<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">Measurements and tests</concept></collMode>
        <collMode xml:lang="sv">Mätningar och tester<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=sv-5.0.0">Mätningar och tester</concept></collMode>
        <collMode xml:lang="en">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.</concept></collMode>
        <collMode xml:lang="en">Measurements and tests<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">Measurements and tests</concept></collMode>
        <collMode xml:lang="sv">Mätningar och tester<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=sv-5.0.0">Mätningar och tester</concept></collMode>
        <collMode xml:lang="en">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.</concept></collMode>
        <collMode xml:lang="en">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.<concept vocab="DDI Mode of Collection" vocabURI="https://vocabularies.cessda.eu/v2/vocabularies/ModeOfCollection/5.0.0?languageVersion=en-5.0.0">A total volume of 300 µl per mouse was prepared by dissolving 2.6 mg of GalNAz in 50 µl DMSO followed by dilution in PBS. The GalNAz injections were given intraperitoneally at 14 days post-infection, and mice were sacrificed 2 h after the injection by cervical dislocation under anesthesia with isoflurane. Whole blood samples from each mouse were collected upon sacrifice. Then, the stomachs were harvested and opened along the greater curvature followed by a gentle wash in sterile PBS to remove chyme. A stripe of the lesser curvature of the stomach containing forestomach, corpus, and antrum was fixed in buffered formaldehyde 4% aqueous solution for 24 h. The fixed tissue was paraffin-embedded and histological slides were prepared with 4 µm thick tissue ribbons. Additionally, two pieces of the corpus (approximately 4 x 4 mm) were collected.  One was placed in RNA-later, and stored at 4°C, the other one was immediately frozen in dry ice. Both samples were later stored at -80°C until use.</concept></collMode>
      </dataColl>
    </method>
    <dataAccs>
      <useStmt>
        <restrctn xml:lang="en">Access to data through SND. Data are freely accessible.</restrctn>
        <restrctn xml:lang="sv">Åtkomst till data via SND. Data är fritt tillgängliga.</restrctn>
        <conditions elementVersion="info:eu-repo-Access-Terms vocabulary">openAccess</conditions>
      </useStmt>
    </dataAccs>
    <othrStdyMat>
      <relPubl>
        <citation>
          <titlStmt>
            <titl xml:lang="sv">Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells S. Sharba, N. Navabi, M. Padra, J. A. Persson, M. P. Quintana-Hayashi, J. K. Gustafsson, et al.

Virulence 2019 Vol. 10 Issue 1 Pages 97-117</titl>
            <parTitl xml:lang="en">Interleukin 4 induces rapid mucin transport, increases mucus thickness and quality and decreases colitis and Citrobacter rodentium in contact with epithelial cells S. Sharba, N. Navabi, M. Padra, J. A. Persson, M. P. Quintana-Hayashi, J. K. Gustafsson, et al.

Virulence 2019 Vol. 10 Issue 1 Pages 97-117</parTitl>
            <IDNo agency="DOI">10.1080/21505594.2019.1573050</IDNo>
          </titlStmt>
          <distStmt>
            <distDate date="2019">2019</distDate>
          </distStmt>
        </citation>
      </relPubl>
      <relPubl>
        <citation>
          <titlStmt>
            <titl xml:lang="sv">Helicobacter pylori infection impairs the mucin production rate and turnover in the murine gastric mucosa. Navabi, M. E. Johansson, S. Raghavan and S. K. Linden

Infect Immun 2013 Vol. 81 Issue 3 Pages 829-37</titl>
            <parTitl xml:lang="en">Helicobacter pylori infection impairs the mucin production rate and turnover in the murine gastric mucosa. Navabi, M. E. Johansson, S. Raghavan and S. K. Linden

Infect Immun 2013 Vol. 81 Issue 3 Pages 829-37</parTitl>
            <IDNo agency="DOI">10.1128/IAI.01000-12</IDNo>
          </titlStmt>
          <distStmt>
            <distDate date="2013">2013</distDate>
          </distStmt>
        </citation>
      </relPubl>
      <relPubl>
        <citation>
          <titlStmt>
            <titl xml:lang="sv">Histological effect of (R)-alpha-methylhistamine on ethanol damage in rat gastric mucosa: influence on mucus production. Morini, D. Grandi, M. L. Arcari, G. Galanti and G. Bertaccini

Dig Dis Sci 1997 Vol. 42 Issue 5 Pages 1020-8</titl>
            <parTitl xml:lang="en">Histological effect of (R)-alpha-methylhistamine on ethanol damage in rat gastric mucosa: influence on mucus production. Morini, D. Grandi, M. L. Arcari, G. Galanti and G. Bertaccini

Dig Dis Sci 1997 Vol. 42 Issue 5 Pages 1020-8</parTitl>
            <IDNo agency="DOI">10.1023/a:1018841204104</IDNo>
          </titlStmt>
          <distStmt>
            <distDate date="1997">1997</distDate>
          </distStmt>
        </citation>
      </relPubl>
    </othrStdyMat>
  </stdyDscr>
</codeBook>